CD79A and irritable bowel syndrome: Comparing the CD group against the IBS patients (35.1% CD vs. 4.3% IBS; p < 0.0001) and HC groups (35.1% CD vs. 2.3% HC; p < 0.0001), the CD patients showed the highest and statistically significant prevalence of IgA AZA antibodies.